Equity Profile

CVS

CVS Health Corporation

Health CareHealth Care Services$116.1B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

CVS Health Corporation is a leading health care company that provides a range of services, including pharmacy benefits management, retail pharmacy, and health insurance. With a market cap of $116 billion, CVS plays a significant role in the health care sector, especially as consumer spending on health services continues to grow.

Key Metrics to Watch

EPS

Earnings per share (EPS) is a crucial indicator of the company's profitability and financial health this quarter.

Not available

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its services.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q1 2026, CVS reported an EPS of $2.57, exceeding expectations by 16.39%. The stock reacted positively, gaining 7.65% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are looking for CVS to continue its trend of beating earnings expectations, especially after a strong Q1 performance. However, there is uncertainty about revenue growth.

Bull Case

If CVS can maintain its strong EPS growth and show robust revenue figures, it could signal strong operational efficiency and market demand.

Bear Case

Concerns about rising costs and competition in the health care sector could lead to disappointing revenue and profit margins.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's $2.57?

Given CVS's strong EPS performance in recent quarters, any significant deviation could impact investor confidence.

How has revenue growth trended compared to previous quarters?

Revenue growth is critical for assessing the company's ability to expand its market share and maintain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating CVS's ability to leverage its pharmacy benefits management segment for growth, which could lead to a stronger-than-expected EPS.

Supporting Evidence

CVS has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

The options market is pricing in a larger move than historical averages, suggesting potential for a surprise.

Recent insider buying activity may indicate confidence in the company's future performance.

Key Risk

If CVS's EPS comes in below $2.40, it could undermine the bullish sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating CVS's ability to sustain its earnings growth amidst rising costs and competitive pressures.

Bull Confirmed If

An EPS of $2.70 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $2.40 would raise concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move for CVS's stock following the earnings report, indicating heightened investor uncertainty.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests the stock could rise by around 4.06%, confirming strong operational momentum.

In-Line / Cautious

A cautious in-line report may lead to muted stock movement as investors assess future growth prospects.

Miss

If CVS misses expectations, the stock could decline, with historical patterns suggesting a drop of around 5.45%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

Senate only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-ARJohn BoozmanSen.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any guidance on revenue growth expectations for the upcoming quarters.
2Details on cost management strategies and their impact on margins.
3Updates on the performance of the pharmacy benefits management segment.
4Insights into competitive pressures and how CVS plans to address them.
5Management's outlook on consumer health trends and spending.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

Insider activity

PreviewView

Jul

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share (EPS) is a crucial indicator of the company's profitability and financial health this quarter.

Not available

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its services.

Not available

Wall Street expectations, options signals, track record, and call prep available with Pro.

CVS Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+17.38%

Avg Stock Reaction

+4.06%

Last Quarter Recap

In Q1 2026, CVS reported an EPS of $2.57, exceeding expectations by 16.39%. The stock reacted positively, gaining 7.65% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are looking for CVS to continue its trend of beating earnings expectations, especially after a strong Q1 performance. However, there is uncertainty about revenue growth.

Bull Case

If CVS can maintain its strong EPS growth and show robust revenue figures, it could signal strong operational efficiency and market demand.

Bear Case

Concerns about rising costs and competition in the health care sector could lead to disappointing revenue and profit margins.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to last quarter's $2.57?

Given CVS's strong EPS performance in recent quarters, any significant deviation could impact investor confidence.

How has revenue growth trended compared to previous quarters?

Revenue growth is critical for assessing the company's ability to expand its market share and maintain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating CVS's ability to leverage its pharmacy benefits management segment for growth, which could lead to a stronger-than-expected EPS.

Supporting Evidence

CVS has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

The options market is pricing in a larger move than historical averages, suggesting potential for a surprise.

Recent insider buying activity may indicate confidence in the company's future performance.

Key Risk

If CVS's EPS comes in below $2.40, it could undermine the bullish sentiment surrounding the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating CVS's ability to sustain its earnings growth amidst rising costs and competitive pressures.

Bull Confirmed If

An EPS of $2.70 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $2.40 would raise concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±7.03%

Historical Avg

±5.4%

Pricing rich

The options market is pricing in a significant move for CVS's stock following the earnings report, indicating heightened investor uncertainty.

Options are pricing ±7.0% while CVS has averaged ±5.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.7%

Calls (563K)P/C Ratio: 0.42Puts (383K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If CVS beats expectations, history suggests the stock could rise by around 4.06%, confirming strong operational momentum.

In-Line / Cautious

A cautious in-line report may lead to muted stock movement as investors assess future growth prospects.

Miss

If CVS misses expectations, the stock could decline, with historical patterns suggesting a drop of around 5.45%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·0 sells

Members

Senate only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-ARJohn BoozmanSen.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any guidance on revenue growth expectations for the upcoming quarters.
2Details on cost management strategies and their impact on margins.
3Updates on the performance of the pharmacy benefits management segment.
4Insights into competitive pressures and how CVS plans to address them.
5Management's outlook on consumer health trends and spending.